QA: Hh Biotechnology Holdings Co in us_realestate/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000828878_2015_Hh_Biotechnology_Holdings_Co.pdf

Logs

warning No stock price available subcommand.plot {}
warning Missing logo subcommand.report {}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 1.852386642736301e-08, 'aggregate_val': 53984409, 'exp_sum': 53984410, 'exp_to_value': {'RealEstateInvestments': 0, 'IntangibleAssets': 0, 'remainder_Assets': 53984410}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('EntityCommonStockSharesOutstanding')"}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000828878')"}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('EntityCommonStockSharesOutstanding')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000828878, Hh Biotechnology Holdings Co

  xvar xval
0 RealEstateInvestmentPropertyAtCost 0
1 RealEstateInvestmentPropertyAccumulatedDepreciation 0
2 remainder_RealEstateInvestments 0
3 LiabilitiesLongTerm 0
4 LiabilitiesCurrent 34,847,908
5 remainder_Liabilities 0
6 IntangibleAssets 0
7 remainder_Assets 53,984,409
8 LeaseIncome 5,822,420
9 remainder_Revenues 0
10 CostOfRevenue 5,055,732
11 DepreciationAndAmortization 24,137
12 GeneralAndAdministrativeExpense 4,404,991
13 remainder_Expenses 1,276,213
14 remainder_NetIncome 625,233
15 remainder_ComprehensiveNetIncome -562,119
  yvar yval
0 RealEstateInvestments 0
1 Liabilities 34,847,908
2 Assets 53,984,409
3 Revenues 5,822,420
4 Expenses 10,761,073
5 StockholdersEquity 19,136,501
6 NetIncome -4,313,420
7 ComprehensiveNetIncome -4,594,480
8 BaseVar 150,596,957
9 EconomicCapitalRatio -0.844

Edgar->Model Mapping

Feature Distribution

Change over Time